Ovasave, a FemTech startup based in Hub71 and specializing in fertility and women’s health, has successfully closed a $1.2 million pre-seed funding round.
The round was led by Plus Venture Capital, Annex Investments, and 25madison, with participation from strategic family offices and investors from the UAE and Saudi Arabia.
Founded in 2023 by Torkia M. and Majd Abu Zant, Ovasave is on a mission to transform how women access fertility and hormonal health services through a comprehensive digital platform that offers:
- At-home hormonal and ovarian reserve testing,
- Telehealth consultations,
- A tailored reproductive supplement suite, and
- Access to accredited fertility preservation and egg-freezing centers.
The company also launched a corporate benefits program designed to empower employers to support female employees’ reproductive wellness as part of broader workplace wellbeing initiatives.
The new funding will support Ovasave’s regional expansion strategy, including its entry into the Saudi market this summer, expanding institutional partnerships, and launching the next version of its mobile application.
